Thus, this engineering approach will be a useful tool for design of IgG antibodies with tailored mode-of-action towards a specific target and indication. "Development of the next generation of ...

HK) presented the mechanism of action (MOA) research findings of its innovative bispecific antibody, AK132, targeting both Claudin18.2 (CLDN18.2) and CD47. AK132 is an asymmetric bispecific ...

Antibodies come in several subtypes ... DNase or their release was prevented by a substance with a novel mode of action, the immune defense remained intact. The researchers were able to ...

Thus, this engineering approach will be a useful tool for design of IgG antibodies with tailored mode-of-action towards a specific target and indication. “Development of the next generation of ...